Ignite Creation Date:
2025-12-24 @ 5:09 PM
Ignite Modification Date:
2025-12-29 @ 12:28 AM
Study NCT ID:
NCT00147550
Status:
TERMINATED
Last Update Posted:
2013-09-13
First Post:
2005-09-02
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
MEK Inhibitor PD-325901 To Treat Advanced Breast Cancer, Colon Cancer, And Melanoma.
Sponsor:
Pfizer
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2004-02
Start Date Type:
None
Primary Completion Date:
2007-05
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-07
Completion Date Type:
ACTUAL
First Submit Date:
2005-09-02
First Submit QC Date:
None
Study First Post Date:
2005-09-07
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2013-09-11
Last Update Post Date:
2013-09-13
Last Update Post Date Type:
ESTIMATED